Health Disparities in Cardiovascular Endocrinology, Lipids and Fatty Liver Disease
Presenter: Megan Haymart, MD (University of Michigan)
No relevant financial relationships

Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
Presenter: Dr. Fernando Bril, MD (University of Alabama at Birmingham)
No relevant financial relationships

Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
Presenter: Ryan Pearce, PhD (Quest Diagnostics)
No relevant financial relationships

Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
Presenter: Timothy Collier, PhD (Quest Diagnostics)
No relevant financial relationships

Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
Presenter: Srilaxmi Kalavalapalli, MS (University of Florida)
No relevant financial relationships

Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
Presenter: Michael McPhaul, MD (Quest Diagnostics)
No relevant financial relationships

Differences in HDL Particle Composition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Liver Fibrosis May Explain Higher Cardiovascular Risk
Presenter: Kenneth Cusi, MD (University of Florida)
No relevant financial relationships

Health Disparities in Cardiovascular Endocrinology, Lipids and Fatty Liver Disease
Presenter: Dr. Giovanna Muscogiuri, MD (University of Naples Federico II)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Dr. Daniel M Huck, MD, MPH (Brigham and Women's Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Allie Walpert, MSN (Massachusetts General Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Suman Srinivasa, MD (Massachusetts General Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Marcelo DiCarli, MD (Brigham and Women's Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Sanjna Iyengar, BS (Massachusetts General Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Grace Shen, BS (Massachusetts General Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Terresa Thomas, MBBCh (Massachusetts General Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Suman Srinivasa, MD, MS (Massachusetts General Hospital)
No relevant financial relationships

Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
Presenter: Steven Grinspoon, MD (Massachusetts General Hospital)
No relevant financial relationships

Prediabetes is a Risk Factor for Myocardial Infarction-A National Inpatient Sample Study
Presenter: Geethika Thota, MBBS (Saint Peter University Hospital/Rutgers Robert Wood Johnson Hospital)
No relevant financial relationships

Prediabetes is a Risk Factor for Myocardial Infarction-A National Inpatient Sample Study
Presenter: Dr. kavin raj, MBBS (St Peters Medical Center)
No relevant financial relationships

Prediabetes is a Risk Factor for Myocardial Infarction-A National Inpatient Sample Study
Presenter: Keerthana Jyotheeswara Pillai, MBBS (Saint Peter University Hospital/Rutgers Robert Wood Johnson Hospital)
No relevant financial relationships

Prediabetes is a Risk Factor for Myocardial Infarction-A National Inpatient Sample Study
Presenter: Hongxiu Luo, MD (Saint Peter University Hospital/Rutgers Robert Wood Johnson Hospital)
No relevant financial relationships

Prediabetes is a Risk Factor for Myocardial Infarction-A National Inpatient Sample Study
Presenter: Shuang Xu, PhD (Saint Peter University Hospital/Rutgers Robert Wood Johnson Hospital)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Shripa Amatya, MSc (Department of Molecular and Cellular Physiology LSU Health Sciences Center-Shreveport)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Mr. Oscar Gomez-Torres, PhD (Universidad Castilla-la Mancha (Spain). Department of Molecular and Cellular Physiology, Center for Cardiovascular Diseases and Sciences, and Center for Redox Biology and Cardiovascular Disease)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Lilly Kamberov, BS (Department of Molecular and Cellular Physiology, Center for Cardiovascular Diseases and Sciences, and Center for Redox Biology and Cardiovascular Disease)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Hemangini Dhaibar, PhD (Department of Molecular and Cellular Physiology LSU Health Sciences Center-Shreveport)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Pranshu Khanna, BS (Department of Molecular and Cellular Physiology, Center for Cardiovascular Diseases and Sciences, and Center for Redox Biology and Cardiovascular Disease)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Orem Ron, PhD (Department of Pathology, LSU Health Sciences Center, Shreveport, LA)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Arif Yurgadul, PhD (Department of Molecular and Cellular Physiology, Center for Cardiovascular Diseases and Sciences, and Center for Redox Biology and Cardiovascular Disease)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Wayne A Orr, PhD (Department of Pathology, LSU Health Sciences Center, Shreveport, LA)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Kelly Nunez, PhD (Institute of Translational Research, Ochsner Health System, New Orleans, LA)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Paul Thevenot, PhD (Institute of Translational Research, Ochsner Health System, New Orleans, LA)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Ari Cohen, MD (Institute of Translational Research, Ochsner Health System, New Orleans, LA)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Hrishikesh Samant, MD (Ochsner Multiorgan Transplant Center, New Orleans,)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Jonathan S Alexander, PhD (Department of Molecular and Cellular Physiology, Center for Cardiovascular Diseases and Sciences, and Center for Redox Biology and Cardiovascular Disease)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Emma Burgos-Ramos, PhD (Facultad de Ciencias Ambientales y Bioquímica, Universidad de Castilla-La Mancha, Toledo, Spain)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Adrian Chapa-Rodriguez, MD (Department of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital, 1 Children's Way, Little Rock, AR)
No relevant financial relationships

SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Presenter: Diana Cruz-Topete, PhD (Department of Molecular and Cellular Physiology, Center for Cardiovascular Diseases and Sciences, and Center for Redox Biology and Cardiovascular Disease)
No relevant financial relationships

The Relationship of Lipoprotein Fractions as Assessed by Ion Mobility and Insulin Resistance as Measured by the Insulin Suppression Test
Presenter: Dr. Michael McPhaul, MD (Quest Diagnostics)
No relevant financial relationships

The Relationship of Lipoprotein Fractions as Assessed by Ion Mobility and Insulin Resistance as Measured by the Insulin Suppression Test
Presenter: Fahim Abbasi, MD (Stanford University)
No relevant financial relationships

The Relationship of Lipoprotein Fractions as Assessed by Ion Mobility and Insulin Resistance as Measured by the Insulin Suppression Test
Presenter: Josh Knowles, MD, PhD (Stanford University)
No relevant financial relationships

The Relationship of Lipoprotein Fractions as Assessed by Ion Mobility and Insulin Resistance as Measured by the Insulin Suppression Test
Presenter: Michael Caulfield, PhD (Quest Diagnostics)
No relevant financial relationships

The Relationship of Lipoprotein Fractions as Assessed by Ion Mobility and Insulin Resistance as Measured by the Insulin Suppression Test
Presenter: Charles Rowland, PhD (Quest Diagnostics)
No relevant financial relationships